Support your liver function with potent Dihydromyricetin supplements

Short Description:


Product Detail

Product Tags

Product function and application

Rattan tea extract dihydromyricetin (DMY), is a kind of wild woody vine plant (rattan tea) extract of grape family snake grape (rattan tea), also known as dihydromyricetin, dihydromyricetin, snake glucin and so on.
Dimyricetin is one of the main active components of Tengma tea. It has many biological functions, such as scavenging free radicals, anti-oxidation, anti-hypertension, anti-thrombus, anti-tumor, anti-inflammatory and so on. Dihydromyricetin as a special Chemicalbook flavonoid compound, in addition to the general characteristics of flavonoids, but also has the effects of lifting alcoholism, preventing alcoholic liver, fatty liver, inhibiting liver cell deterioration, reducing the incidence of liver cancer, is a good product to protect the liver and cure the hangover.
Chemical properties White crystalline powder, soluble in methanol, ethanol, DMSO and other organic solvents, from the stems and leaves of rattan tea. Uses A flavonol with antioxidant and anticancer activities, with anti-alcoholism effects. Uses This product is the extract of rattan tea, a grape plant. The main active ingredient in Rattan tea is flavonoids, which has many unique effects such as scavenging free radicals, anti-oxidation, anti-thrombus, anti-tumor, anti-inflammatory, etc. Dihydromyricetin is a special flavonoid compound. Besides the general properties of flavonoids, dihydromyricetin can also relieve alcohol poisoning, prevent alcoholic liver and fatty liver, inhibit liver cell deterioration, and reduce the incidence of liver cancer.
Hydromyricetin is widely used in the treatment of respiratory infection, alcoholism of Chinese patent medicine preparations, such as tablets, capsules, granules. In recent years, anti-tumor pharmacodynamics studies have found that small molecule compounds of ophiopsin, one of its active components, have strong anticancer effects. The research of dihydromyricetin has obtained the invention patent authorization in the application field of preparing anti-leukemia and nasopharyngeal cancer drugs. It is ready to enter the clinical trial stage as a class of new drugs. The development of Chemicalbook injection is expected to provide a new treatment for leukemia and nasopharyngeal carcinoma patients. Microherb completed the extraction and purification technology of vine tea extract (total flavones of Vitis sericulata) and dihydromyricetin, and completed the related toxicity experiments and efficacy studies, and developed instant tea, total flavones of Vitis sericulata buccal tablets, dihydromyricetin Jiebao liver capsules and other health foods with dihydromyricetin as the effective additive.


  • Previous:
  • Next:

  • Write your message here and send it to us

    Inquiry for Pricelist

    For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
    inquiry now